VT02956 is an inhibitor of LATS with an IC50 of 0.76 nM for LATS1 and 0.52 nM for LATS2. It targets the Hippo signaling pathway and suppresses the growth of ER+ breast cancer cell lines and patient-derived tumor organoids, as well as the expression of ESR1.
Formula:
C22H24ClN5O
Target:
YAP
* VAT and and shipping costs not included. Errors and price changes excepted
